About
Products
Knolens
KnolScapes
Knolens
Knolens SLR
Knolens
KnolQuest
Knolens
Edge
Knolens
DataNexus
Platform
Solutions
KnolSights
Signup For Free
4B Technologies Announces Positive Phase 1 Results for Novel Non-Opioid Chronic Pain Therapy
4B Technologies announced positive topline results from a Phase 1 study of 4B03-04, a humanized monoclonal antibody for chronic pain. The trial demon...
Copyright © 2025. All rights reserved
About
Terms of Service
Privacy Policy
Home/
KnloSights/
Clinical Trial Updates/
4B Technologies Announces Positive Phase 1 Results for Novel Non-Opioid Chronic Pain Therapy